Andrew Bauerschmidt

Papers

Total Citations

H-Index

About

Andrew Bauerschmidt is a clinical researcher whose work sits at the intersection of neurocritical care and medical robotics. His primary research focus is on improving outcomes for patients with subarachnoid hemorrhage (SAH), particularly through the early detection and management of delayed cerebral ischemia (DCI) secondary to vasospasm. Bauerschmidt’s most notable contribution is his pioneering investigation into a novel robotic transcranial doppler (TCD) system. In his highly cited 2022 study, he demonstrated that this robotic system can measure cerebral blood flow velocities with greater accuracy and precision than traditional manual acquisition. This work is critical, as precise TCD monitoring is the standard of care for SAH patients, yet manual readings are often subject to operator variability. By showing that robotic TCD can enhance reliability, Bauerschmidt has laid the groundwork for more consistent, data-driven neurocritical care. With 27 citations on this key paper alone, his work is gaining traction among clinicians and engineers seeking to automate and standardize bedside monitoring. Bauerschmidt’s research represents a meaningful step toward integrating robotics into the intensive care unit, promising safer, more effective surveillance for the most vulnerable neurological patients.